Two partial responses and six patients with stable disease out of 28. Aprea is expanding the trial — and being unusually direct that the goal is finding out who responds before committing to Phase 2.
A single small tablet, once daily — aimed specifically at people whose resistance or drug interactions had kept them on complex multi-pill regimens everyone else moved on from.
Every CAR-T dose today is manufactured from one patient’s own cells. Growing functional helper T cells from stem cells instead is the bottleneck the whole off-the-shelf field is stuck behind.
The 2026–27 shots target XFG, which accounts for about 79% of US cases. The more consequential change is who is eligible — no longer everyone.
No gene therapy, no implant, no surgery — a light-sensitive molecule applied as a drop took over the job of dead photoreceptors and worked in ordinary room lighting.
Polycythemia vera is managed by draining blood from patients repeatedly, for life. Mimrylo achieves the same iron restriction pharmacologically — and 77% of patients needed no phlebotomy at all.
An 8% reduction sounds modest until you notice the comparator was not placebo but another GLP-1 drug that had already proven cardiovascular benefit.
Keeping harvested human skin alive for a month — 30 times longer than usual — lets you screen compounds on real tissue. Outer Bio raised $23M and is deliberately avoiding calling itself a drug company.
Bats carry lethal viruses without illness, rarely get cancer, and live decades. Eight genomes suggest these are not three separate talents but one, shaped by constant viral pressure.
Britain ended sugar rationing in September 1953, creating an accidental experiment: children born months apart had very different early diets. Seventy years on, the differences are still measurable.
Plenty of drugs clear eosinophils from the esophagus without making swallowing easier. Tezspire hit both endpoints — which is what makes it a credible challenger to the only approved biologic.
Dermatomyositis has been managed with steroids for decades, and the steroids do their own damage. The measure that matters here is how many patients got off them.